NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 8,400.00
0.00 (0.00%)
At close: Jun 29, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 107.87 billion as of June 29, 2026. Its market cap has increased by 21.04% in one year.
Market Cap
107.87B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
70.00
Stock Price
8,400.00
Market Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 107.87B, an increase of 44.61%. That is a compound annual growth rate of 4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 107.87B | -34.10% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 161.29B |
| Bio Solution | 152.25B |
| Prestige Biologics | 151.23B |
| ISU Abxis | 129.26B |
| ViGenCell | 123.61B |
| TiumBio | 110.69B |
| Cell Biotech | 102.66B |
| CORESTEMCHEMON | 88.19B |